Introduction
It is well established that patients with chronic obstructive pulmonary disease (COPD) present impaired skeletal muscle function, which plays a role in reducing exercise tolerance 1 . Although the impairment of lower limb (LL) muscles are largely responsible for limitations in activities such as walking and climbing stairs, it is known that activities of daily living (ADL) performed with upper limbs (UL), especially unsupported, are also poorly tolerated by patients with COPD 2 .
Although reduced skeletal muscle function has been reported in both the lower limbs and the shoulder girdle muscles of patients with COPD, it has been speculated that the metabolic and structural adaptations differ among LL and UL muscles 3 . For LL, the quadriceps femoris (QF) is the peripheral muscle most commonly tested in COPD For UL, a variety of muscles has been studied, making it difficult to generalize UL performance results 2, 8 . Because of the finding that the isometric handgrip force is conserved in patients with COPD, some studies infer that the upper limb function is preserved [9] [10] [11] . It appears that oxidative capacity is preserved or even increased in the deltoid muscles of patients with COPD 9 , as opposed to what is observed in lower limb muscles. One possible explanations for this difference is that patients continue to perform, to a certain extent, the ADLs that involve the upper limbs but reduce their performance of the activities that involve the lower limbs, adopting a sedentary lifestyle in order to minimize dyspnea. That finding was prevalent in patients with severe COPD.
Study design
This was a prospective, cross-sectional study performed in two visits (24 hours apart). The subjects were assessed at the same time of day (between 2:00 and 3:00 pm), and they were instructed to refrain from any strenuous activities in the 72h before the procedure. After study enrollment, the patients were randomized to determine the order of evaluation of the muscles (QF and MD or MD and QF). On the first visit, the patients underwent the following sequence of tests: (1) .
Skeletal muscle function assessment
The strength of the QF was obtained on the dominant leg by MVIC. This measurement was taken with the subject seated on a leg extension chair (Carci Body mass index (BMI) was calculated as weight/height 2 (kg/m 2 ). Body weight was assessed with a beam scale to the nearest 0.1 kg, with subjects standing barefoot and in light clothing. Body height was determined to the nearest 0.1 cm with subjects standing barefoot.
Estimation of mid-arm muscle area
The mid-arm muscle area (AMA) was estimated using the following equation: AMA = mid-arm circumference, cm -(0.314 x triceps skinfold, cm) 2 / (4 x 3.14) 30 . The mid-arm circumference was measured at the midpoint of the arm, between the tip of the acromion and the olecranon process, with a steel tape with the arm relaxed and parallel to the trunk. A skinfold caliper (Lange®, Cambridge, MD) was used to measure the triceps skinfold, which was taken over the triceps muscle, halfway between the elbow and acromial process of the scapula
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. The unit was expressed in cm 2 .
Estimation of mid-thigh muscle area
To estimate the mid-thigh muscle area (TMA), mid-thigh circumference (MTC) and anterior thigh skinfold (ATS) were taken midway between the inguinal crease and the top of the patella, with the patient standing with feet shoulder-width apart. The same steel tape and skinfold caliper were used as for the AMA. The TMA was obtained as follows: TMA = mid-arm thigh, cm -(0.314 x anterior thigh skinfold, cm) 2 / (4 x 3.14) 32 . The unit was expressed in cm 
Statistical analysis
Based on the results from the five first patients, we obtained a standard deviation 
Results
Baseline characteristics of the 21 patients (two women) are shown in Table 1 .
According to the GOLD criteria, most of the patients (n = 15) presented severe obstruction, and the six remaining patients had moderate obstruction.
Insert Table 1   Table 2 shows the variables obtained from the strength and endurance tests. MD showed reduced MVIC compared to QF (P < 0.05). However, no significant difference was observed when MVIC was corrected for muscle mass, but we found statistical difference for the limit of tolerance in the endurance test corrected for the maximal voluntary isometric contraction (P < 0.05). The submaximal workload performed by MD was lower than that of QF. Although the same MVIC percentage (60%) for the endurance test was used for both muscles, the endurance time for MD was about 40% of that performed by QF (Figure 1 
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Insert Table 2
Insert Figure 1 A significant drop in MVIC was observed in MD, at 10 and 60 minutes, but not 30 min and 24h after the endurance test (Figure 2 ).
Insert Figure 2
Figure 3A shows a significant increase in RMS of MD compared to QF only in 25% of endurance test (% duration). Figure 3B shows a greater decline in MF throughout the endurance test for MD compared to QF.
Insert Figure 3
There was a significant difference in the slope of the MF over time between MD and QF (-3.77 ± 1.4 and -2.68 ± 1.2, respectively; p < 0.03).
In relation to perceived exertion, the majority of the patients stopped the endurance test due to local muscle fatigue (MD: 18 patients and QF: 16 patients), and three patients presented higher scores of dyspnea for MD and five patients for QF.
Ratings of perceived exertion for dyspnea and fatigue increased significantly for QF (from 1.3 ± 0.8 to 2.1 ± 1.2 and 1.3 ± 1.0 to 2.8 ± 1.3, respectively) and MD (from 1.4 ± 0.9 to 2.7 ± 1.9 and 1.6 ± 1.1 to 3.2 ± 1.7, respectively). When dyspnea and fatigue scores were corrected for endurance time, higher values of this index were observed for MD (0.07 and 0.08, respectively) compared to QF (0.02 and 0.03, respectively) (P <0.05). 
Discussion
This study compared fatigue between two representative muscles of the upper and lower limbs in patients with COPD. The main finding is that, despite similar muscle efficiency, muscle fatigue was evident earlier and was more pronounced in the MD.
The lower muscle strength presented by MD compared to QF was expected.
Similar results have been showed for the biceps brachii (BB) in relation to QF 18 . Although Gosker et al 18 have measured the fat free mass, muscular strength has not been corrected for muscle mass, which reflects the efficiency of muscle. In this context, in our study, the difference observed in muscle strength between MD and QF disappeared after correcting them for the respective muscle mass. Therefore, muscle efficiency was similar between MD and QF, indicating that the contractile apparatus was preserved 19 . Then, the difference in endurance time between MD and QF suggests that neither strength nor muscle mass would be a determinant of muscle endurance.
The reduction of muscular endurance, regardless of loss of muscle mass, in patients with COPD has been related to intrinsic muscular alterations, such as reduction of type I fibers and reduced oxidative enzyme activity 1 . Consequently, there is a predominance of anaerobic metabolism, resulting in early lactate accumulation and muscle fatigue. In absolute values, the dyspnea and fatigue scores were similar at the peak of both endurance tests. However, the endurance time was lower for MD than for QF (Table 2) . When corrected for the endurance time, i.e. work performed, dyspnoea and fatigue, in fact, were superior for MD compared to QF. Local muscle fatigue possibly occurred due to increased lactate production per unit of muscle mass. A possible mechanism related to dyspnea is the change in lung volume during the UL activities, characterized by decreased forced vital capacity, increased functional residual capacity, and inspiratory capacity decrease 12, 33 . In addition to the changes in lung mechanics, it is speculated that reduction of blood flow during elevation of the UL leads to increased production of lactate, which increases ventilation demand and, consequently, dyspnea 34, 35 .
One of the most common methods used to quantify the development of muscle fatigue is the decline in maximum strength 36 . In our study, a greater drop in strength was observed for the MD compared to the QF (Figure 1 ). This result is similar to that found by Gosker et al. 16 ; however, the magnitude of the reduction in strength was lower in our study in both muscles (MD: 20.6% and QF: 10.6%) when compared to the study of Gosker et al. 16 (BB: 42% and QF: 28%). The larger decline in strength observed in the study of Gosker et al. 16 may be attributed to a more intense fatigue-inducing protocol (i.e., 15 sequential maximal voluntary contractions at an angular velocity of 90° s), as well as to differences in disease severity compared to our patients (FEV 1 : 32 ± 11% vs. 46 ± 10%, respectively) and the fat free mass and the strength was also lower in patients than control subjects.
Several studies have evaluated QF fatigability after cycling, walking, repeated maximum voluntary contractions, and local endurance tests [37] [38] [39] . However, to the best of our knowledge, only our study has analyzed the recovery time of fatigue for UL after a fatigue-inducing protocol. In addition to the greater decrease in strength compared to the QF, MD presented longer recovery time of the baseline MVIC. Beyond smaller muscle mass, this finding may be explained by the dual function of the accessory respiratory muscles during unsupported arm exercise, ventilation, and postural maintenance, which can contribute to more pronounced fatigue 15 . Unlike that observed in the lower limb muscles, alterations in fiber-type distribution and decreased metabolic capacity do not seem to be involved in early fatigue of the upper limb muscles. This assertion is based on previous studies that demonstrated preserved or even increased Although widely used for evaluation of muscle fatigue, submaximal sustained isometric contraction [40] [41] [42] [43] [44] has the disadvantage of being dependent on motivation.
However, we associate the use of electromyography during the tests which resulted in a more objective evaluation of muscle fatigue. In this context, a 4% decrease in MF has been recommended as an indirect marker of contractile fatigue evaluated by sEMG 45 .
Therefore, while our patients certainly presented muscle fatigue for both QF and MD, it was more pronounced in the MD, as seen in the higher slope in the MF over time ( Figure 2B ). This data can not be directly compared with other studies in patients with COPD because we are unable to find any study that has analyzed it. Comparing with healthy subjects 46 , a more pronounced drop in the slope of the MF over time was Currently resistance training is one of the components of the pulmonary rehabilitation program for patients with COPD. Based on our findings, we suggest that training the upper limbs in patients with COPD should be accomplished with high repetition/low resistance to increase muscular endurance. Further studies measuring pulmonary gas exchange while patients perform a fatigue-inducing protocol should be conducted to verify whether changes in electromyography outcomes reflect higher oxygen consumption, carbon dioxide production, and ventilation. In addition, studies evaluating lung volume, especially inspiratory capacity, could help to explain the increased perception of dyspnea observed in the upper limb endurance tests.
In conclusion, we have found that patients with COPD presented with higher fatigability of upper limb muscle compared to lower limb muscle with longer recovery time. 
